why choose us

Clinical Trials Search

Showing 11,340 of 132,366 result(s)
A Study on the Effect of Bariatric Surgery on Glucose Metabolism in Chinese Obese and Type 2 Diabetes Patients

Status: NOT_YET_RECRUITING

Condition: Diabete Type 2

Interventions: Nine blood samples were collected from subjects within 4 hours of oral glucose administration, 0 min before oral glucose administration, and 10, 20, 3

Date: 2023-05-30

Evaluating a Virtual Stepped Care Portal in Youth Awaiting Tertiary Chronic Pain Care: An Implementation-Effectiveness Hybrid Type III Study

Status: NOT_YET_RECRUITING

Condition: Chronic Pain

Interventions: Youth from different ages, sexes, gender, sexual orientations, races, dwelling and school;employment status will receive access to the Power over

Date: 2023-05-30

Phase II Study to Evaluate the Efficacy and Safety of 177Lu-Dotatate in the First-line Treatment of Patients With Locally Advanced or Metastatic, Somatostatin Receptor-positive G2 or G3 Gastroenteropancreatic Neuroendocrine Tumors

Status: NOT_YET_RECRUITING

Condition: Neuroendocrine Tumors

Interventions: Lutetium[177Lu] Oxodotreotide InjectionFour administrations of 7.4 GBq (200 mCi) Lutetium[177Lu] Oxodotreotide Injection administered at 8 +;- 1-

Date: 2023-05-30

Comparison of the Effects of Telerehabilitation Based Motor and Cognitive Dual Task Exercises in Patients With Parkinson's Disease

Status: NOT_YET_RECRUITING

Condition: Parkinson Disease

Interventions: Only physical exercise and motor dual tasks will be given

Date: 2023-05-30

Constrained Balloon Combined With Drug-coated Balloon Angioplasty for Femoropopliteal Lesion

Status: NOT_YET_RECRUITING

Condition: Peripheral Arterial Disease

Interventions: Vascular preparation with chocolate balloons prior to drug-coated balloon angioplasty

Date: 2023-05-30

Naptumomab Estafenatox in Combination With Pembrolizumab Preceded by Obinutuzumab in Patients With Urothelial Cancers

Status: NOT_YET_RECRUITING

Condition: Urothelial Carcinoma

Interventions: 5 or 10 µg;kg IV naptumomab estafenatox will be given on the first four days of every 21-day treatment cycle for 6 cycles

Date: 2023-05-30

Ameliorating Stroke-induced Hemianopia Via Multisensory Training

Status: NOT_YET_RECRUITING

Condition: Hemianopia, Homonymous

Interventions: The procedure involves repeatedly presenting identical visual-auditory stimuli at a single location in the hemianopic field (initially at 45° of eccen

Date: 2023-05-30

Portal Vein Occlusion is a Valuable Predictor for Postoperative Nausea and Vomiting

Status: NOT_YET_RECRUITING

Condition: Postoperative Nausea and Vomiting

Interventions: this is no intervention

Date: 2023-05-30

Immunity in Persons Fully Vaccinated Against Measles, Mumps and Rubella and Responses to Booster Vaccination

Status: NOT_YET_RECRUITING

Condition: Mumps

Interventions: a single dose of MMR-containing vaccine (as M-M-R-VaxPro), in adults having previously received 2 lifetime doses of MMR-containing vaccine

Date: 2023-05-30

Double Helix Design Defocus Lens Spectacle (RACE) for Myopia Control

Status: Completed

Condition: Myopia, Progressive

Interventions: Double Helix Design Defocus Lens Spectacle wearing more than 10h;day.

Date: 2023-05-30